BioSpace News Archive

The Jason Foundation, Inc. launched a new statewide initiative to combat suicide deaths, Tennessee Won’t Be Silent.

New COVID-19 case projections released by PolicyLab at Children’s Hospital of Philadelphia paint a sobering picture for much of the United States over the next four weeks—forecasting significant continued virus resurgence in known hotspots such as Houston and Miami and rising risk once again in communities across the Mid-Atlantic and Midwest.

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2020 financial results on Thursday, August 6, 2020, prior to its earnings call at 8:00 a.m. ET.

Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report second quarter 2020 financial results on Wednesday, July 22, 2020, after the close of market.

BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced estimated preliminary revenue for the second quarter of 2020 of $9.6 million to $9.8 million, representing 43% to 46% growth over the same quarter in 2019.

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), today announced that it has received U.S. Food & Drug Administration (FDA) approval under a premarket approval supplement for 3T full-body magnetic resonance imaging (MRI) conditional labeling for the Axonics r-SNM System®.

Invacare Corporation (NYSE:IVC)(the “Company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced that Matthew E. Monaghan, chairman, president and chief executive officer will present at the 20th Annual New Ideas Summer Conference on Tuesday, July 14, 2020.

Annexon, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye, today announced the closing of a $100 million financing led by new investor Redmile Group.

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced that it filed for 510(k) premarket clearance wit

Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women’s health clinical research and diagnostic development, today announced the appointment of Mary Gunn, PhD, MBA, LLM, as Chief Operating Officer (COO).